This Pharma Company Incorporates a Wholly Owned Subsidiary in Dubai; FII’s Increase Stake
Join Us
Follow Us
With a new Dubai subsidiary, is Alkem Laboratories gearing up for its next phase of international growth?
✨ AI Powered Summary
Alkem Laboratories Ltd has announced the incorporation of a wholly owned subsidiary (WOS) named Alkem Pharma Trading FZCO in Dubai, UAE, marking a strategic step towards expanding its international footprint.
The newly incorporated entity has been established with an authorised share capital of AED 36,70,000, divided into 3,67,000 equity shares of AED 10 each. The subscribed capital stands at the same level, indicating full subscription of the authorised capital.
The incorporation, completed on March 27, 2026, is aligned with Alkem’s long-term vision to strengthen its export capabilities. The Dubai-based subsidiary is expected to act as a key hub for distributing the Company’s pharmaceutical products across African, South East Asian and other non-UAE markets.
Dubai’s strategic geographic location and well-established trade infrastructure make it an ideal base for facilitating global exports. Through Alkem Pharma Trading FZCO, the Company aims to enhance supply chain efficiency, improve market access, and capitalise on growing demand in emerging markets.
FII Shareholding Update
The Foreign Institutional Investors (FIIs) holding in Alkem Laboratories Ltd has witnessed a marginal increase over the recent quarters.
FII stake stood at 9.47 per cent as of September 2025, which increased to 9.97 per cent in December 2025.
About Alkem Laboratories Ltd
Alkem Laboratories Ltd is one of the leading Indian multinational pharmaceutical company engaged in the development, manufacturing, and marketing of branded generics, speciality pharmaceuticals, and nutraceuticals across India and several international markets. Alkem was founded in 1973 and is now among the top‑10 pharmaceutical companies in India, with a strong presence in both acute and chronic‑therapy segments.
Alkem Laboratories Ltd Share Price Performance
On Monday, Alkem Laboratories Ltd's share price closed at Rs 5,364.50, down Rs 75.50 (1.39 per cent).
On a year-to-date (YTD) basis, the stock has declined by 2.10 per cent, while it has delivered a return of 9.44 per cent over the past year.
Disclaimer: The article is for informational purposes only and not investment advice.